Skip to main content

Advanced Search

Haematologica
  • Home
  • Current Issue
  • Ahead Of Print
  • Archive
  • Submit a Manuscript
    • Author Guidelines
    • Reviewer Guidelines
    • Submit a Manuscript
    • Track a Manuscript
  • About Us
    • About Haematologica
    • Editorial Board
    • Our Policies
  • More
    • Advertising
    • Rights & Permissions
    • Alerts
    • Feedback
    • Contact
Factors related to the relative survival of patients with diffuse large B-cell lymphoma in a population-based study in France: does socio-economic status have a role?
Sandra Le Guyader-Peyrou, Sébastien Orazio, Olivier Dejardin, Marc Maynadié, Xavier Troussard, Alain Monnereau
Haematologica March 2017 102: 584-592; doi:10.3324/haematol.2016.152918
Sandra Le Guyader-Peyrou
Registre des Hémopathies Malignes de la Gironde, Institut Bergonie, Bordeaux, France University of Bordeaux, Inserm, Bordeaux Population Health Research Center, Team EPICENE, UMR 1219, F-33000, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: s.leguyaderpeyrou@bordeaux.unicancer.fr
Sébastien Orazio
Registre des Hémopathies Malignes de la Gironde, Institut Bergonie, Bordeaux, France University of Bordeaux, Inserm, Bordeaux Population Health Research Center, Team EPICENE, UMR 1219, F-33000, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Olivier Dejardin
University Hospital of Caen, U1086 INSERM UCBN «Cancers & Préventions», France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Marc Maynadié
Registre des Hémopathies Malignes de Côte d’Or, EA4184, Université de Bourgogne, Dijon, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Xavier Troussard
Registre des Hémopathies Malignes de Basse Normandie, Caen, France Laboratoire d’Hématologie, CHU de Caen, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alain Monnereau
Registre des Hémopathies Malignes de la Gironde, Institut Bergonie, Bordeaux, France University of Bordeaux, Inserm, Bordeaux Population Health Research Center, Team EPICENE, UMR 1219, F-33000, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site

Author Affiliations

  1. Sandra Le Guyader-Peyrou1,2⇑,
  2. Sébastien Orazio1,2,
  3. Olivier Dejardin3,
  4. Marc Maynadié4,
  5. Xavier Troussard5,6 and
  6. Alain Monnereau1,2
  1. 1Registre des Hémopathies Malignes de la Gironde, Institut Bergonie, Bordeaux, France
  2. 2University of Bordeaux, Inserm, Bordeaux Population Health Research Center, Team EPICENE, UMR 1219, F-33000, France
  3. 3University Hospital of Caen, U1086 INSERM UCBN «Cancers & Préventions», France
  4. 4Registre des Hémopathies Malignes de Côte d’Or, EA4184, Université de Bourgogne, Dijon, France
  5. 5Registre des Hémopathies Malignes de Basse Normandie, Caen, France
  6. 6Laboratoire d’Hématologie, CHU de Caen, France
  1. Correspondence
    : s.leguyaderpeyrou{at}bordeaux.unicancer.fr
View Abstract
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 102 no. 3 584-592
DOI 
https://doi.org/10.3324/haematol.2016.152918
PubMed 
27909221

Published By 
Haematologica
Print ISSN 
0390-6078
Online ISSN 
1592-8721

History 
  • Received July 19, 2016
  • Accepted November 24, 2016
  • .

Article Versions

  • previous version (December 1, 2016 - 01:29).
  • You are viewing the most recent version of this article.
Copyright & Usage 
Copyright© Ferrata Storti Foundation Material published in Haematologica is covered by copyright. All rights are reserved to the Ferrata Storti Foundation. Use of published material is allowed under the following terms and conditions:https://creativecommons.org/licenses/by-nc/4.0/legalcode. Copies of published material are allowed for personal or internal use. Sharing published material for non-commercial purposes is subject to the following conditions:https://creativecommons.org/licenses/by-nc/4.0/legalcode, sect. 3. Reproducing and sharing published material for commercial purposes is not allowed without permission in writing from the publisher.

Author Information

  1. Sandra Le Guyader-Peyrou1,2⇑,
  2. Sébastien Orazio1,2,
  3. Olivier Dejardin3,
  4. Marc Maynadié4,
  5. Xavier Troussard5,6 and
  6. Alain Monnereau1,2
  1. 1Registre des Hémopathies Malignes de la Gironde, Institut Bergonie, Bordeaux, France
  2. 2University of Bordeaux, Inserm, Bordeaux Population Health Research Center, Team EPICENE, UMR 1219, F-33000, France
  3. 3University Hospital of Caen, U1086 INSERM UCBN «Cancers & Préventions», France
  4. 4Registre des Hémopathies Malignes de Côte d’Or, EA4184, Université de Bourgogne, Dijon, France
  5. 5Registre des Hémopathies Malignes de Basse Normandie, Caen, France
  6. 6Laboratoire d’Hématologie, CHU de Caen, France
  1. Correspondence
    : s.leguyaderpeyrou{at}bordeaux.unicancer.fr
View Abstract

Statistics from Altmetric.com

Article usage

Article usage: December 2016 to November 2019

AbstractFullPdf
Dec 2016239079
Jan 201788022
Feb 201774638
Mar 201722268107
Apr 2017824837
May 20176196128
Jun 20174224225
Jul 20171114420
Aug 201718827
Sep 201785422
Oct 201747016
Nov 201763512
Dec 201720469
Jan 2018194012
Feb 201893616
Mar 2018144511
Apr 20182324
May 201834710
Jun 201885810
Jul 20183392
Aug 20183378
Sep 20180265
Oct 201814217
Nov 201824212
Dec 20181577
Jan 20193648
Feb 201911627
Mar 20190614
Apr 201903010
May 201945319
Jun 201924417
Jul 201974616
Aug 2019148117
Sep 201923410
Oct 201963612
Nov 2019132913
PreviousNext
Back to top

Vol 102 Issue 3

Haematologica: 102 (3)
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
Email

Thank you for your interest in spreading the word about Haematologica.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Factors related to the relative survival of patients with diffuse large B-cell lymphoma in a population-based study in France: does socio-economic status have a role?
(Your Name) has forwarded a page to you from Haematologica
(Your Name) thought you would like to see this page from the Haematologica web site.
Print
Citation Tools
Factors related to the relative survival of patients with diffuse large B-cell lymphoma in a population-based study in France: does socio-economic status have a role?
Sandra Le Guyader-Peyrou, Sébastien Orazio, Olivier Dejardin, Marc Maynadié, Xavier Troussard, Alain Monnereau
Haematologica Mar 2017, 102 (3) 584-592; DOI: 10.3324/haematol.2016.152918

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Sandra Le Guyader-Peyrou, Sébastien Orazio, Olivier Dejardin, Marc Maynadié, Xavier Troussard, Alain Monnereau
Haematologica Mar 2017, 102 (3) 584-592; DOI: 10.3324/haematol.2016.152918
del.icio.us logo Digg logo Reddit logo Technorati logo Twitter logo CiteULike logo Connotea logo Facebook logo Google logo Mendeley logo
Request Permissions
  • Tweet Widget
  • Facebook Like
  • Alert me when this article is cited
  • Alert me if a correction is posted

Jump To

  • Article
    • Abstract
    • Introduction
    • Methods
    • Results
    • Discussion
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

More in this TOC Section

  • Minimal residual disease prior to allogeneic hematopoietic cell transplantation in acute myeloid leukemia: a meta-analysis
  • Long-term observation reveals high-frequency engraftment of human acute myeloid leukemia in immunodeficient mice
  • Association between quality of response and outcomes in patients with newly diagnosed mantle cell lymphoma receiving VR-CAP versus R-CHOP in the phase 3 LYM-3002 study
Show more Articles

Related Articles

Cited By...

What about you?
Tell us your interests and get all the new contents of Haematologica in advance

 

 

Navigate

  • Home
  • Current issue
  • Ahead of print
  • Archive
  • Info for
    • Authors
    • Reviewers
    • Advertisers
    • Subscribers
  • About us
    • About Haematologica
    • Editorial Board
    • Our policies

For Authors

  • Author guidelines
  • Submit Manuscript
  • Track Manuscript

For Reviewers

  • Reviewer Guidelines
  • Access Your Profile
  • Access Your Tasks
  • 2014 reviewers

For Advertisers

  • Information For Advertising

Education

  • Review Articles
  • Guideline Articles

More

  • Rights & Permissions
  • Advertising
  • Alerts
  • Feedback
  • Contact
  • App

Copyright © 2019 by the Ferrata Storti Foundation

ISSN 0390-6078 print

ISSN 1592-8721 online